Latest Eisai Stories
Card Enables Eligible Patients to Pay No More than $75 for their BELVIQ Prescription* WOODCLIFF LAKE, N.J., Jan. 20, 2015 /PRNewswire/ -- Eisai Inc.
LUGANO, Switzerland, January 12, 2015 /PRNewswire/ -- Helsinn Healthcare SA announces that it has entered into a settlement agreement with Sandoz Inc.
- Timing of initiatives aligns with seasonal focus on weight loss - SAN DIEGO, Jan. 9, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
RnRMarketResearch.com adds Thyroid Cancer and Esophageal Cancer Pipeline Review H2 2014 to its store.
FOR U.S. MEDIA ONLY WOODCLIFF LAKE, N.J., Dec.
TOKYO, Nov. 17, 2014 /PRNewswire/ -- Eisai Co., Ltd.
RnRMarketResearch.com adds Alzheimer’s disease – Pipeline Review, H2 2014 market research report of 1141 pages to the Alzheimer’s disease and Alzheimer drugs industry research collection
WASHINGTON, Nov. 7, 2014 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that David J.
Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.
-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.